Filing Details
- Accession Number:
- 0001209191-21-047745
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-22 16:24:13
- Reporting Period:
- 2021-07-20
- Accepted Time:
- 2021-07-22 16:24:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1699382 | Pmv Pharmaceuticals Inc. | PMVP | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1341642 | Henry David Mack | C/O Pmv Pharmaceuticals, Inc. 8 Clarke Drive, Suite 3 Cranbury NJ 08512 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-07-20 | 1,029 | $0.53 | 13,499 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-07-20 | 1,029 | $35.53 | 12,470 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-07-21 | 26,767 | $0.53 | 39,237 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-07-21 | 26,767 | $35.76 | 12,470 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-07-20 | 1,029 | $0.00 | 1,029 | $0.53 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-07-21 | 26,767 | $0.00 | 26,767 | $0.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 473,841 | 2025-05-11 | No | 4 | M | Direct | |
| 447,074 | 2025-05-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 227,915 | Indirect | See footnote |
| Common Stock | 56,978 | Indirect | See footnote |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $36.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- The shares are held of record by The Mack-Mulligan Revocable Trust, for which the Reporting Person serves as co-trustee.
- The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust, for which the Reporting Person serves as co-trustee.
- The shares subject to the option are fully vested and immediately exercisable.
Billionaire Hedge Funds
